Data from European Society for Medical Oncology (ESMO) - Curated by Toby Galbraith - Last updated 07 October 2016

Status

live

Latest update

04-Oct-16

In order to complement the already available European Society for Medical Oncology (ESMO) Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with malignant lymphomas, ESMO organised a consensus conference on mature B-cell lymphomas and chronic lymphocytic leukaemia to develop recommendations on critical subjects difficult to consider in detail in the ESMO Clinical Practice Guidelines. The following areas were identified: (i) the elderly patient, (ii) prognostic factors suitable for clinical use and (iii) the ‘ultra-high-risk’ group.

This manuscript presents recommendations on prognostic factors suitable for clinical use and focuses on the three less common lymphoproliferative malignancies: marginal zone lymphoma, mantle cell lymphoma and peripheral T-cell lymphomas.

Read full guideline

Comments

You will need to login, to leave a comment.

epgonline.org is not monitored for collection of adverse event reports. Any adverse events should be reported to your national reporting agency and/or the manufacturer.

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Chronic Lymphocytic Leukaemia (CLL)

Refine your knowledge of chronic lymphocytic leukaemia (CLL) with information on pathophysiology, diagnosis, treatment options and more

Visit Chronic Lymphocytic Leukaemia (CLL)


Transplantation

See information on best practice in solid organ transplantation, and expert discussions on related hot topics.

Visit Transplantation


Related Content